Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Dermatology

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 332 articles: HTML format

Single Articles

June 2008
1. MONTAGUT C , Sharma SV, Shioda T, McDermott U, et al
   Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma.
   Cancer Res. 2008;68:4853-61.
   PubMed     Related articles    Abstract available
   
   
   
2. WANG L , Damania B
   Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.
   Cancer Res. 2008;68:4640-8.
   PubMed     Related articles    Abstract available
   
   
   
3. CRUZ-MUNOZ W , Man S, Xu P, Kerbel RS, et al
   Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
   Cancer Res. 2008;68:4500-5.
   PubMed     Related articles    Abstract available
   
   
   
4. MOLHOEK KR , Griesemann H, Shu J, Gershenwald JE, et al
   Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.
   Cancer Res. 2008;68:4392-7.
   PubMed     Related articles    Abstract available
   
   
   
5. LO RS , Witte ON
   Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytes.
   Cancer Res. 2008;68:4248-57.
   PubMed     Related articles    Abstract available
   
   
   May 2008
6. ZHENG D , Bode AM, Zhao Q, Cho YY, et al
   The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development.
   Cancer Res. 2008;68:3992-8.
   PubMed     Related articles    Abstract available
   
   
   
7. CONNEROTTE T , Van Pel A, Godelaine D, Tartour E, et al
   Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities.
   Cancer Res. 2008;68:3931-3940.
   PubMed     Related articles    Abstract available
   
   
   
8. YUSUF N , Nasti TH, Katiyar SK, Jacobs MK, et al
   Antagonistic Roles of CD4+ and CD8+ T-Cells in 7,12-Dimethylbenz(a)anthracene Cutaneous Carcinogenesis.
   Cancer Res. 2008;68:3924-30.
   PubMed     Related articles    Abstract available
   
   
   
9. FANTIN VR , Loboda A, Paweletz CP, Hendrickson RC, et al
   Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma.
   Cancer Res. 2008;68:3785-94.
   PubMed     Related articles    Abstract available
   
   
   
10. AUGUSTINE CK , Yoshimoto Y, Gupta M, Zipfel PA, et al
    Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment.
    Cancer Res. 2008;68:3777-84.
    PubMed     Related articles    Abstract available
    
    
    
11. MOORE T , Carbajal S, Beltran L, Perkins SN, et al
    Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels.
    Cancer Res. 2008;68:3680-8.
    PubMed     Related articles    Abstract available
    
    
    
12. VAN KILSDONK JW , Wilting RH, Bergers M, van Muijen GN, et al
    Attenuation of Melanoma Invasion by a Secreted Variant of Activated Leukocyte Cell Adhesion Molecule.
    Cancer Res. 2008;68:3671-3679.
    PubMed     Related articles    Abstract available
    
    
    
13. CHEUNG M , Sharma A, Madhunapantula SV, Robertson GP, et al
    Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.
    Cancer Res. 2008;68:3429-39.
    PubMed     Related articles    Abstract available
    
    
    
14. MARSH D , Dickinson S, Neill GW, Marshall JF, et al
    alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation.
    Cancer Res. 2008;68:3295-303.
    PubMed     Related articles    Abstract available
    
    
    
15. DYNEK JN , Chan SM, Liu J, Zha J, et al
    Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
    Cancer Res. 2008;68:3124-32.
    PubMed     Related articles    Abstract available
    
    
    
16. FARRUGIA DJ , Agarwal MK, Pankratz VS, Deffenbaugh AM, et al
    Functional assays for classification of BRCA2 variants of uncertain significance.
    Cancer Res. 2008;68:3523-31.
    PubMed     Related articles    Abstract available
    
    
    
17. MACEDO LF , Sabnis GJ, Goloubeva OG, Brodie A, et al
    Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model.
    Cancer Res. 2008;68:3516-22.
    PubMed     Related articles    Abstract available
    
    
    
18. BARNETT DH , Sheng S, Charn TH, Waheed A, et al
    Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.
    Cancer Res. 2008;68:3505-15.
    PubMed     Related articles    Abstract available
    
    
    
19. BENDRIK C , Robertson J, Gauldie J, Dabrosin C, et al
    Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
    Cancer Res. 2008;68:3405-12.
    PubMed     Related articles    Abstract available
    
    
    
20. MUELLER KL , Hunter LA, Ethier SP, Boerner JL, et al
    Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.
    Cancer Res. 2008;68:3314-22.
    PubMed     Related articles    Abstract available
    
    
    
21. YANG XH , Richardson AL, Torres-Arzayus MI, Zhou P, et al
    CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.
    Cancer Res. 2008;68:3204-13.
    PubMed     Related articles    Abstract available
    
    
    
22. KAKLAMANI VG , Sadim M, Hsi A, Offit K, et al
    Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk.
    Cancer Res. 2008;68:3178-84.
    PubMed     Related articles    Abstract available
    
    
    
23. SMID M , Wang Y, Zhang Y, Sieuwerts AM, et al
    Subtypes of breast cancer show preferential site of relapse.
    Cancer Res. 2008;68:3108-14.
    PubMed     Related articles    Abstract available
    
    
    April 2008
24. FELICETTI F , Errico MC, Bottero L, Segnalini P, et al
    The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.
    Cancer Res. 2008;68:2745-54.
    PubMed     Related articles    Abstract available
    
    
    
25. CALDON CE , Swarbrick A, Lee CS, Sutherland RL, et al
    The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini.
    Cancer Res. 2008;68:3026-36.
    PubMed     Related articles    Abstract available
    
    
    
26. SHOR B , Zhang WG, Toral-Barza L, Lucas J, et al
    A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis.
    Cancer Res. 2008;68:2934-43.
    PubMed     Related articles    Abstract available
    
    
    
27. AHMAD R , Raina D, Meyer C, Kufe D, et al
    Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1)-->signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3.
    Cancer Res. 2008;68:2920-6.
    PubMed     Related articles    Abstract available
    
    
    
28. SUN H , Berquin IM, Owens RT, O'Flaherty JT, et al
    Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells.
    Cancer Res. 2008;68:2912-9.
    PubMed     Related articles    Abstract available
    
    
    
29. TRAN M , Rousselle P, Nokelainen P, Tallapragada S, et al
    Targeting a tumor-specific laminin domain critical for human carcinogenesis.
    Cancer Res. 2008;68:2885-94.
    PubMed     Related articles    Abstract available
    
    
    
30. HAWSAWI NM , Ghebeh H, Hendrayani SF, Tulbah A, et al
    Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes.
    Cancer Res. 2008;68:2717-25.
    PubMed     Related articles    Abstract available
    
    
    
31. YAMADA N , Nishida Y, Tsutsumida H, Hamada T, et al
    MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.
    Cancer Res. 2008;68:2708-16.
    PubMed     Related articles    Abstract available
    
    
    
32. VERMEER MH , van Doorn R, Dijkman R, Mao X, et al
    Novel and highly recurrent chromosomal alterations in Sezary syndrome.
    Cancer Res. 2008;68:2689-98.
    PubMed     Related articles    Abstract available
    
    
    
33. SHAI A , Pitot HC, Lambert PF
    p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.
    Cancer Res. 2008;68:2622-31.
    PubMed     Related articles    Abstract available
    
    
    
34. CHAN SW , Lim CJ, Guo K, Ng CP, et al
    A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells.
    Cancer Res. 2008;68:2592-8.
    PubMed     Related articles    Abstract available
    
    
    
35. LU YP , Lou YR, Peng QY, Xie JG, et al
    Effect of caffeine on the ATR/Chk1 pathway in the epidermis of UVB-irradiated mice.
    Cancer Res. 2008;68:2523-9.
    PubMed     Related articles    Abstract available
    
    
    
36. ENGELMANN K , Shen H, Finn OJ
    MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1.
    Cancer Res. 2008;68:2419-26.
    PubMed     Related articles    Abstract available
    
    
    
37. SOUNDARARAJAN S , Chen W, Spicer EK, Courtenay-Luck N, et al
    The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
    Cancer Res. 2008;68:2358-65.
    PubMed     Related articles    Abstract available
    
    
    
38. WANG X , Masri S, Phung S, Chen S, et al
    The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop.
    Cancer Res. 2008;68:2259-65.
    PubMed     Related articles    Abstract available
    
    
    
39. COLETTA RD , Christensen KL, Micalizzi DS, Jedlicka P, et al
    Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation.
    Cancer Res. 2008;68:2204-13.
    PubMed     Related articles    Abstract available
    
    
    
40. NAIK MU , Naik TU, Suckow AT, Duncan MK, et al
    Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion.
    Cancer Res. 2008;68:2194-203.
    PubMed     Related articles    Abstract available
    
    
    
41. SEIFEDDINE R , Dreiem A, Blanc E, Fulchignoni-Lataud MC, et al
    Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
    Cancer Res. 2008;68:2158-65.
    PubMed     Related articles    Abstract available
    
    
    
42. ZHANG S , Phelan CM, Zhang P, Rousseau F, et al
    Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.
    Cancer Res. 2008;68:2154-7.
    PubMed     Related articles    Abstract available
    
    
    
43. DOURDIN N , Schade B, Lesurf R, Hallett M, et al
    Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis.
    Cancer Res. 2008;68:2122-31.
    PubMed     Related articles    Abstract available
    
    
    
44. DAIRKEE SH , Seok J, Champion S, Sayeed A, et al
    Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients.
    Cancer Res. 2008;68:2076-80.
    PubMed     Related articles    Abstract available
    
    
    March 2008
45. POS Z , Wiener Z, Pocza P, Racz M, et al
    Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma.
    Cancer Res. 2008;68:1997-2005.
    PubMed     Related articles    Abstract available
    
    
    
46. SHIN YC , Joo CH, Gack MU, Lee HR, et al
    Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression.
    Cancer Res. 2008;68:1751-9.
    PubMed     Related articles    Abstract available
    
    
    
47. ZHANG YX , Knyazev PG, Cheburkin YV, Sharma K, et al
    AXL is a potential target for therapeutic intervention in breast cancer progression.
    Cancer Res. 2008;68:1905-15.
    PubMed     Related articles    Abstract available
    
    
    
48. YAMAGUCHI N , Oyama T, Ito E, Satoh H, et al
    NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
    Cancer Res. 2008;68:1881-8.
    PubMed     Related articles    Abstract available
    
    
    
49. BIERIE B , Stover DG, Abel TW, Chytil A, et al
    Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Cancer Res. 2008;68:1809-19.
    PubMed     Related articles    Abstract available
    
    
    
50. CHENG AS , Culhane AC, Chan MW, Venkataramu CR, et al
    Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome.
    Cancer Res. 2008;68:1786-96.
    PubMed     Related articles    Abstract available
    
    
    
51. DANES CG , Wyszomierski SL, Lu J, Neal CL, et al
    14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling.
    Cancer Res. 2008;68:1760-7.
    PubMed     Related articles    Abstract available
    
    
    
52. SHEKHAR MP , Gerard B, Pauley RJ, Williams BO, et al
    Rad6B is a positive regulator of beta-catenin stabilization.
    Cancer Res. 2008;68:1741-50.
    PubMed     Related articles    Abstract available
    
    
    
53. XIA W , Nagase S, Montia AG, Kalachikov SM, et al
    BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer.
    Cancer Res. 2008;68:1667-74.
    PubMed     Related articles    Abstract available
    
    
    
54. MCDONALD PC , Oloumi A, Mills J, Dobreva I, et al
    Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival.
    Cancer Res. 2008;68:1618-24.
    PubMed     Related articles    Abstract available
    
    
    
55. BEMIS LT , Chen R, Amato CM, Classen EH, et al
    MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.
    Cancer Res. 2008;68:1362-8.
    PubMed     Related articles    Abstract available
    
    
    
56. CHAKRABORTY AK , Liang K, DiGiovanna MP
    Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer.
    Cancer Res. 2008;68:1538-45.
    PubMed     Related articles    Abstract available
    
    
    
57. FUJII T , Kawahara A, Basaki Y, Hattori S, et al
    Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
    Cancer Res. 2008;68:1504-12.
    PubMed     Related articles    Abstract available
    
    
    
58. SHATTUCK DL , Miller JK, Carraway KL 3rd, Sweeney C, et al
    Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells.
    Cancer Res. 2008;68:1471-7.
    PubMed     Related articles    Abstract available
    
    
    
59. LABELLE M , Schnittler HJ, Aust DE, Friedrich K, et al
    Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
    Cancer Res. 2008;68:1388-97.
    PubMed     Related articles    Abstract available
    
    
    
60. RIZKI A , Weaver VM, Lee SY, Rozenberg GI, et al
    A human breast cell model of preinvasive to invasive transition.
    Cancer Res. 2008;68:1378-87.
    PubMed     Related articles    Abstract available
    
    
    
61. PLOTNIKOV A , Li Y, Tran TH, Tang W, et al
    Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptor.
    Cancer Res. 2008;68:1354-61.
    PubMed     Related articles    Abstract available
    
    
    
62. MELIS JP , Wijnhoven SW, Beems RB, Roodbergen M, et al
    Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
    Cancer Res. 2008;68:1347-53.
    PubMed     Related articles    Abstract available
    
    
    
63. JIANG P , Enomoto A, Jijiwa M, Kato T, et al
    An actin-binding protein Girdin regulates the motility of breast cancer cells.
    Cancer Res. 2008;68:1310-8.
    PubMed     Related articles    Abstract available
    
    
    
64. SCHMID T , Jansen AP, Baker AR, Hegamyer G, et al
    Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.
    Cancer Res. 2008;68:1254-60.
    PubMed     Related articles    Abstract available
    
    
    February 2008
65. MARZEC M , Halasa K, Kasprzycka M, Wysocka M, et al
    Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.
    Cancer Res. 2008;68:1083-91.
    PubMed     Related articles    Abstract available
    
    
    
66. GRAVES CW , Philips ST, Bradley SV, Oravecz-Wilson KI, et al
    Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.
    Cancer Res. 2008;68:1064-73.
    PubMed     Related articles    Abstract available
    
    
    
67. FURUTA E , Pai SK, Zhan R, Bandyopadhyay S, et al
    Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.
    Cancer Res. 2008;68:1003-11.
    PubMed     Related articles    Abstract available
    
    
    
68. POTAPOVA A , Hoffman AM, Godwin AK, Al-Saleem T, et al
    Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Cancer Res. 2008;68:998-1002.
    PubMed     Related articles    Abstract available
    
    
    
69. SARRIO D , Rodriguez-Pinilla SM, Hardisson D, Cano A, et al
    Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.
    Cancer Res. 2008;68:989-97.
    PubMed     Related articles    Abstract available
    
    
    
70. WANG X , Szabo C, Qian C, Amadio PG, et al
    Mutational analysis of thirty-two double-strand DNA break repair genes in breast and pancreatic cancers.
    Cancer Res. 2008;68:971-5.
    PubMed     Related articles    Abstract available
    
    
    
71. CHEN LH , Jiang CC, Watts R, Thorne RF, et al
    Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein.
    Cancer Res. 2008;68:834-42.
    PubMed     Related articles    Abstract available
    
    
    
72. VALLACCHI V , Daniotti M, Ratti F, Di Stasi D, et al
    CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.
    Cancer Res. 2008;68:715-23.
    PubMed     Related articles    Abstract available
    
    
    
73. LIN WM , Baker AC, Beroukhim R, Winckler W, et al
    Modeling genomic diversity and tumor dependency in malignant melanoma.
    Cancer Res. 2008;68:664-73.
    PubMed     Related articles    Abstract available
    
    
    
74. HOEK KS , Eichhoff OM, Schlegel NC, Dobbeling U, et al
    In vivo switching of human melanoma cells between proliferative and invasive states.
    Cancer Res. 2008;68:650-6.
    PubMed     Related articles    Abstract available
    
    
    
75. LEE KW , Kang NJ, Heo YS, Rogozin EA, et al
    Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine.
    Cancer Res. 2008;68:946-55.
    PubMed     Related articles    Abstract available
    
    
    
76. TRIMBOLI AJ , Fukino K, de Bruin A, Wei G, et al
    Direct evidence for epithelial-mesenchymal transitions in breast cancer.
    Cancer Res. 2008;68:937-45.
    PubMed     Related articles    Abstract available
    
    
    
77. SEGAL NH , Parsons DW, Peggs KS, Velculescu V, et al
    Epitope landscape in breast and colorectal cancer.
    Cancer Res. 2008;68:889-92.
    PubMed     Related articles    Abstract available
    
    
    
78. ISHII Y , Waxman S, Germain D
    Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.
    Cancer Res. 2008;68:852-60.
    PubMed     Related articles    Abstract available
    
    
    
79. MASSARWEH S , Osborne CK, Creighton CJ, Qin L, et al
    Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.
    Cancer Res. 2008;68:826-33.
    PubMed     Related articles    Abstract available
    
    
    
80. YIN L , Castagnino P, Assoian RK
    ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition.
    Cancer Res. 2008;68:800-7.
    PubMed     Related articles    Abstract available
    
    
    
81. FINETTI P , Cervera N, Charafe-Jauffret E, Chabannon C, et al
    Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.
    Cancer Res. 2008;68:767-76.
    PubMed     Related articles    Abstract available
    
    
    
82. BREMM A , Walch A, Fuchs M, Mages J, et al
    Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
    Cancer Res. 2008;68:707-14.
    PubMed     Related articles    Abstract available
    
    
    
83. YAROSH W , Barrientos T, Esmailpour T, Lin L, et al
    TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases.
    Cancer Res. 2008;68:693-9.
    PubMed     Related articles    Abstract available
    
    
    
84. MARTINEZ-CRUZ AB , Santos M, Lara MF, Segrelles C, et al
    Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.
    Cancer Res. 2008;68:683-92.
    PubMed     Related articles    Abstract available
    
    
    
85. LEE JH , Horak CE, Khanna C, Meng Z, et al
    Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility.
    Cancer Res. 2008;68:639-44.
    PubMed     Related articles    Abstract available
    
    
    January 2008
86. YUSUF N , Nasti TH, Long JA, Naseemuddin M, et al
    Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.
    Cancer Res. 2008;68:615-22.
    PubMed     Related articles    Abstract available
    
    
    
87. MOSQUERA-MIGUEL A , Alvarez-Iglesias V, Carracedo A, Salas A, et al
    Is mitochondrial DNA variation associated with sporadic breast cancer risk?
    Cancer Res. 2008;68:623-5.
    PubMed     Related articles   
    
    
    
88. SPADERNA S , Schmalhofer O, Wahlbuhl M, Dimmler A, et al
    The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer.
    Cancer Res. 2008;68:537-44.
    PubMed     Related articles    Abstract available
    
    
    
89. ADLER AS , Littlepage LE, Lin M, Kawahara TL, et al
    CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.
    Cancer Res. 2008;68:506-15.
    PubMed     Related articles    Abstract available
    
    
    
90. ZHAO X , Goswami M, Pokhriyal N, Ma H, et al
    Cyclooxygenase-2 expression during immortalization and breast cancer progression.
    Cancer Res. 2008;68:467-75.
    PubMed     Related articles    Abstract available
    
    
    
91. WONG DJ , Nuyten DS, Regev A, Lin M, et al
    Revealing targeted therapy for human cancer by gene module maps.
    Cancer Res. 2008;68:369-78.
    PubMed     Related articles    Abstract available
    
    
    
92. ADRIAENSSENS E , Vanhecke E, Saule P, Mougel A, et al
    Nerve growth factor is a potential therapeutic target in breast cancer.
    Cancer Res. 2008;68:346-51.
    PubMed     Related articles    Abstract available
    
    
    
93. SARFARAZ S , Adhami VM, Syed DN, Afaq F, et al
    Cannabinoids for cancer treatment: progress and promise.
    Cancer Res. 2008;68:339-42.
    PubMed     Related articles    Abstract available
    
    
    
94. SABATINO M , Zhao Y, Voiculescu S, Monaco A, et al
    Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
    Cancer Res. 2008;68:122-31.
    PubMed     Related articles    Abstract available
    
    
    
95. IKUTA S , Edamatsu H, Li M, Hu L, et al
    Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester.
    Cancer Res. 2008;68:64-72.
    PubMed     Related articles    Abstract available
    
    
    
96. MADHUNAPANTULA SV , Robertson GP
    Is B-Raf a good therapeutic target for melanoma and other malignancies?
    Cancer Res. 2008;68:5-8.
    PubMed     Related articles    Abstract available
    
    
    
97. FRIETZE S , Lupien M, Silver PA, Brown M, et al
    CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.
    Cancer Res. 2008;68:301-6.
    PubMed     Related articles    Abstract available
    
    
    
98. KONG X , Wang X, Xu W, Behera S, et al
    Natriuretic peptide receptor a as a novel anticancer target.
    Cancer Res. 2008;68:249-56.
    PubMed     Related articles    Abstract available
    
    
    
99. CHAKRABORTY G , Jain S, Kundu GC
    Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms.
    Cancer Res. 2008;68:152-61.
    PubMed     Related articles    Abstract available
    
    
    
100. AMANN M , Brischwein K, Lutterbuese P, Parr L, et al
     Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3.
     Cancer Res. 2008;68:143-51.
     PubMed     Related articles    Abstract available
     
     
     
101. BRETSCHNEIDER N , Brand H, Miller N, Lowery AJ, et al
     Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner.
     Cancer Res. 2008;68:106-14.
     PubMed     Related articles    Abstract available
     
     
     
102. GURUMURTHY S , Hezel AF, Berger JH, Bosenberg MW, et al
     LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis.
     Cancer Res. 2008;68:55-63.
     PubMed     Related articles    Abstract available
     
     
     
103. GAO B , Xie XJ, Huang C, Shames DS, et al
     RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers.
     Cancer Res. 2008;68:22-5.
     PubMed     Related articles    Abstract available
     
     
     
104. TAMIMI RM , Brugge JS, Freedman ML, Miron A, et al
     Circulating colony stimulating factor-1 and breast cancer risk.
     Cancer Res. 2008;68:18-21.
     PubMed     Related articles    Abstract available
     
     
     December 2007
105. LIAO YH , Hsu SM, Huang PH
     ARMS depletion facilitates UV irradiation induced apoptotic cell death in melanoma.
     Cancer Res. 2007;67:11547-56.
     PubMed     Related articles    Abstract available
     
     
     
106. VARCHETTA S , Gibelli N, Oliviero B, Nardini E, et al
     Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2.
     Cancer Res. 2007;67:11991-9.
     PubMed     Related articles    Abstract available
     
     
     
107. LI L , Ryser S, Dizin E, Pils D, et al
     Oncogenic BARD1 isoforms expressed in gynecological cancers.
     Cancer Res. 2007;67:11876-85.
     PubMed     Related articles    Abstract available
     
     
     
108. LEE HJ , Ji Y, Paul S, Maehr H, et al
     Activation of bone morphogenetic protein signaling by a Gemini vitamin D3 analogue is mediated by Ras/protein kinase C alpha.
     Cancer Res. 2007;67:11840-7.
     PubMed     Related articles    Abstract available
     
     
     
109. WANG T , Zhao J, Ren JL, Zhang L, et al
     Recombinant immunoproapoptotic proteins with furin site can translocate and kill HER2-positive cancer cells.
     Cancer Res. 2007;67:11830-9.
     PubMed     Related articles    Abstract available
     
     
     
110. GERMANIUK-KUROWSKA A , Nag A, Zhao X, Dimri M, et al
     Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation.
     Cancer Res. 2007;67:11789-97.
     PubMed     Related articles    Abstract available
     
     
     
111. O'CALLAGHAN-SUNOL C , Gabai VL, Sherman MY
     Hsp27 modulates p53 signaling and suppresses cellular senescence.
     Cancer Res. 2007;67:11779-88.
     PubMed     Related articles    Abstract available
     
     
     
112. NANGIA-MAKKER P , Raz T, Tait L, Hogan V, et al
     Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers.
     Cancer Res. 2007;67:11760-8.
     PubMed     Related articles    Abstract available
     
     
     
113. HORAK CE , Mendoza A, Vega-Valle E, Albaugh M, et al
     Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
     Cancer Res. 2007;67:11751-9.
     PubMed     Related articles    Abstract available
     
     
     
114. ESSEGHIR S , Todd SK, Hunt T, Poulsom R, et al
     A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer.
     Cancer Res. 2007;67:11732-41.
     PubMed     Related articles    Abstract available
     
     
     
115. OLMEDA D , Moreno-Bueno G, Flores JM, Fabra A, et al
     SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells.
     Cancer Res. 2007;67:11721-31.
     PubMed     Related articles    Abstract available
     
     
     
116. SEMPERE LF , Christensen M, Silahtaroglu A, Bak M, et al
     Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.
     Cancer Res. 2007;67:11612-20.
     PubMed     Related articles    Abstract available
     
     
     
117. ADELAIDE J , Finetti P, Bekhouche I, Repellini L, et al
     Integrated profiling of basal and luminal breast cancers.
     Cancer Res. 2007;67:11565-75.
     PubMed     Related articles    Abstract available
     
     
     
118. BRIDEAU G , Makinen MJ, Elamaa H, Tu H, et al
     Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice.
     Cancer Res. 2007;67:11528-35.
     PubMed     Related articles    Abstract available
     
     
     
119. HINSHELWOOD RA , Huschtscha LI, Melki J, Stirzaker C, et al
     Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
     Cancer Res. 2007;67:11517-27.
     PubMed     Related articles    Abstract available
     
     
     
120. MILSTEIN M , Mooser CK, Hu H, Fejzo M, et al
     RIN1 is a breast tumor suppressor gene.
     Cancer Res. 2007;67:11510-6.
     PubMed     Related articles    Abstract available
     
     
     
121. MOELLER M , Kershaw MH, Cameron R, Westwood JA, et al
     Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells.
     Cancer Res. 2007;67:11428-37.
     PubMed     Related articles    Abstract available
     
     
     
122. WESTBROOK L , Manuvakhova M, Kern FG, Estes NR 2nd, et al
     Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells.
     Cancer Res. 2007;67:11393-401.
     PubMed     Related articles    Abstract available
     
     
     
123. NAIKI-ITO A , Asamoto M, Hokaiwado N, Takahashi S, et al
     Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens.
     Cancer Res. 2007;67:11353-8.
     PubMed     Related articles    Abstract available
     
     
     
124. MORI N , Glunde K, Takagi T, Raman V, et al
     Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
     Cancer Res. 2007;67:11284-90.
     PubMed     Related articles    Abstract available
     
     
     
125. YOKOTA T , Bui T, Liu Y, Yi M, et al
     Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
     Cancer Res. 2007;67:11272-83.
     PubMed     Related articles    Abstract available
     
     
     
126. KATOU F , Ohtani H, Watanabe Y, Nakayama T, et al
     Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
     Cancer Res. 2007;67:11195-201.
     PubMed     Related articles    Abstract available
     
     
     
127. LI N , Zheng Y, Chen W, Wang C, et al
     Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis.
     Cancer Res. 2007;67:11176-85.
     PubMed     Related articles    Abstract available
     
     
     
128. PALMER CP , Mahen R, Schnell E, Djamgoz MB, et al
     Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines.
     Cancer Res. 2007;67:11166-75.
     PubMed     Related articles    Abstract available
     
     
     
129. EBI H , Matsuo K, Sugito N, Suzuki M, et al
     Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer.
     Cancer Res. 2007;67:11158-65.
     PubMed     Related articles    Abstract available
     
     
     
130. HUANG Y , Fernandez SV, Goodwin S, Russo PA, et al
     Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol.
     Cancer Res. 2007;67:11147-57.
     PubMed     Related articles    Abstract available
     
     
     
131. LIN J , Manson JE, Selhub J, Buring JE, et al
     Plasma cysteinylglycine levels and breast cancer risk in women.
     Cancer Res. 2007;67:11123-7.
     PubMed     Related articles    Abstract available
     
     
     
132. RIZKI A , Mott JD, Bissell MJ
     Polo-like kinase 1 is involved in invasion through extracellular matrix.
     Cancer Res. 2007;67:11106-10.
     PubMed     Related articles    Abstract available
     
     
     November 2007
133. SEGRELLES C , Lu J, Hammann B, Santos M, et al
     Deregulated Activity of Akt in Epithelial Basal Cells Induces Spontaneous Tumors and Heightened Sensitivity to Skin Carcinogenesis.
     Cancer Res. 2007;67:10879-10888.
     PubMed     Related articles    Abstract available
     
     
     
134. BLACKBURN JS , Rhodes CH, Coon CI, Brinckerhoff CE, et al
     RNA Interference Inhibition of Matrix Metalloproteinase-1 Prevents Melanoma Metastasis by Reducing Tumor Collagenase Activity and Angiogenesis.
     Cancer Res. 2007;67:10849-10858.
     PubMed     Related articles    Abstract available
     
     
     
135. MERTENS-TALCOTT SU , Chintharlapalli S, Li X, Safe S, et al
     The Oncogenic microRNA-27a Targets Genes That Regulate Specificity Protein Transcription Factors and the G2-M Checkpoint in MDA-MB-231 Breast Cancer Cells.
     Cancer Res. 2007;67:11001-11011.
     PubMed     Related articles    Abstract available
     
     
     
136. MESLIN F , Hamai A, Gao P, Jalil A, et al
     Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
     Cancer Res. 2007;67:10910-9.
     PubMed     Related articles    Abstract available
     
     
     
137. DOWLING RJ , Zakikhani M, Fantus IG, Pollak M, et al
     Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells.
     Cancer Res. 2007;67:10804-10812.
     PubMed     Related articles    Abstract available
     
     
     
138. TRENT S , Yang C, Li C, Lynch M, et al
     Heat shock protein B8, a cyclin-dependent kinase-independent cyclin D1 target gene, contributes to its effects on radiation sensitivity.
     Cancer Res. 2007;67:10774-81.
     PubMed     Related articles    Abstract available
     
     
     
139. SCHUNKE D , Span P, Ronneburg H, Dittmer A, et al
     Cyclooxygenase-2 Is a Target Gene of Rho GDP Dissociation Inhibitor {beta} in Breast Cancer Cells.
     Cancer Res. 2007;67:10694-10702.
     PubMed     Related articles    Abstract available
     
     
     
140. ALEXE G , Dalgin GS, Scanfeld D, Tamayo P, et al
     High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates.
     Cancer Res. 2007;67:10669-76.
     PubMed     Related articles    Abstract available
     
     
     
141. PEREZ-GOMEZ E , Villa-Morales M, Santos J, Fernandez-Piqueras J, et al
     A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis.
     Cancer Res. 2007;67:10268-10277.
     PubMed     Related articles    Abstract available
     
     
     
142. LUKE CT , Oki-Idouchi CE, Cline JM, Lorenzo PS, et al
     RasGRP1 Overexpression in the Epidermis of Transgenic Mice Contributes to Tumor Progression during Multistage Skin Carcinogenesis.
     Cancer Res. 2007;67:10190-10197.
     PubMed     Related articles    Abstract available
     
     
     
143. CURTIS CD , Likhite VS, McLeod IX, Yates JR, et al
     Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression.
     Cancer Res. 2007;67:10600-7.
     PubMed     Related articles    Abstract available
     
     
     
144. HARRELL JC , Dye WW, Harvell DM, Pinto M, et al
     Estrogen Insensitivity in a Model of Estrogen Receptor Positive Breast Cancer Lymph Node Metastasis.
     Cancer Res. 2007;67:10582-10591.
     PubMed     Related articles    Abstract available
     
     
     
145. DOMCHEK SM , Recio A, Mick R, Clark CE, et al
     Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance.
     Cancer Res. 2007;67:10546-10555.
     PubMed     Related articles    Abstract available
     
     
     
146. SANKALA HM , Hait NC, Paugh SW, Shida D, et al
     Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin.
     Cancer Res. 2007;67:10466-74.
     PubMed     Related articles    Abstract available
     
     
     
147. SCUTO A , Zhang H, Zhao H, Rivera M, et al
     RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase.
     Cancer Res. 2007;67:10317-24.
     PubMed     Related articles    Abstract available
     
     
     
148. MOREAU JE , Anderson K, Mauney JR, Nguyen T, et al
     Tissue-Engineered Bone Serves as a Target for Metastasis of Human Breast Cancer in a Mouse Model.
     Cancer Res. 2007;67:10304-10308.
     PubMed     Related articles    Abstract available
     
     
     
149. DATTA S , Hoenerhoff MJ, Bommi P, Sainger R, et al
     Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways.
     Cancer Res. 2007;67:10286-95.
     PubMed     Related articles    Abstract available
     
     
     
150. WIENKE D , Davies GC, Johnson DA, Sturge J, et al
     The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo.
     Cancer Res. 2007;67:10230-40.
     PubMed     Related articles    Abstract available
     
     
     
151. DECOCK J , Long JR, Laxton RC, Shu XO, et al
     Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis.
     Cancer Res. 2007;67:10214-10221.
     PubMed     Related articles    Abstract available
     
     
     
152. ZHANG L , Wali A, Ramana CV, Rishi AK, et al
     Cell growth inhibition by okadaic acid involves gut-enriched Kruppel-like factor mediated enhanced expression of c-Myc.
     Cancer Res. 2007;67:10198-206.
     PubMed     Related articles    Abstract available
     
     
     
153. YANG XR , Pfeiffer RM, Garcia-Closas M, Rimm DL, et al
     Hormonal Markers in Breast Cancer: Coexpression, Relationship with Pathologic Characteristics, and Risk Factor Associations in a Population-Based Study.
     Cancer Res. 2007;67:10608-10617.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     October 2007
154. HUANG X , Yamada Y, Kidoya H, Naito H, et al
     EphB4 Overexpression in B16 Melanoma Cells Affects Arterial-Venous Patterning in Tumor Angiogenesis.
     Cancer Res. 2007;67:9800-8.
     PubMed     Related articles    Abstract available
     
     
     
155. HORTON LW , Yu Y, Zaja-Milatovic S, Strieter RM, et al
     Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth.
     Cancer Res. 2007;67:9791-9.
     PubMed     Related articles    Abstract available
     
     
     
156. JIANG CC , Chen LH, Gillespie S, Wang YF, et al
     Inhibition of MEK Sensitizes Human Melanoma Cells to Endoplasmic Reticulum Stress-Induced Apoptosis.
     Cancer Res. 2007;67:9750-61.
     PubMed     Related articles    Abstract available
     
     
     
157. ZHANG Q , Yu YA, Wang E, Chen N, et al
     Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
     Cancer Res. 2007;67:10038-46.
     PubMed     Related articles    Abstract available
     
     
     
158. AHN KS , Gong X, Sethi G, Chaturvedi MM, et al
     Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases.
     Cancer Res. 2007;67:10004-11.
     PubMed     Related articles    Abstract available
     
     
     
159. RIDER DA , Havenith CE, de Ridder R, Schuurman J, et al
     A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent fc-dependent effector activity.
     Cancer Res. 2007;67:9945-53.
     PubMed     Related articles    Abstract available
     
     
     
160. LIANG Y , Besch-Williford C, Brekken RA, Hyder SM, et al
     Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
     Cancer Res. 2007;67:9929-36.
     PubMed     Related articles    Abstract available
     
     
     
161. LE GALL C , Bellahcene A, Bonnelye E, Gasser JA, et al
     A cathepsin k inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden.
     Cancer Res. 2007;67:9894-902.
     PubMed     Related articles    Abstract available
     
     
     
162. JANI JP , Finn RS, Campbell M, Coleman KG, et al
     Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor.
     Cancer Res. 2007;67:9887-93.
     PubMed     Related articles    Abstract available
     
     
     
163. MONTEL V , Gaultier A, Lester RD, Campana WM, et al
     The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development.
     Cancer Res. 2007;67:9817-24.
     PubMed     Related articles    Abstract available
     
     
     
164. ANDRES-PONS A , Rodriguez-Escudero I, Gil A, Blanco A, et al
     In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.
     Cancer Res. 2007;67:9731-9.
     PubMed     Related articles    Abstract available
     
     
     
165. MACIAS E , Kim Y, Miliani de Marval PL, Klein-Szanto A, et al
     Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
     Cancer Res. 2007;67:9713-20.
     PubMed     Related articles    Abstract available
     
     
     
166. MARTIN RW , Orelli BJ, Yamazoe M, Minn AJ, et al
     RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.
     Cancer Res. 2007;67:9658-65.
     PubMed     Related articles    Abstract available
     
     
     
167. NISHIKAWA N , Toyota M, Suzuki H, Honma T, et al
     Gene amplification and overexpression of PRDM14 in breast cancers.
     Cancer Res. 2007;67:9649-57.
     PubMed     Related articles    Abstract available
     
     
     
168. SEYNHAEVE AL , Hoving S, Schipper D, Vermeulen CE, et al
     Tumor Necrosis Factor {alpha} Mediates Homogeneous Distribution of Liposomes in Murine Melanoma that Contributes to a Better Tumor Response.
     Cancer Res. 2007;67:9455-62.
     PubMed     Related articles    Abstract available
     
     
     
169. DENICOURT C , Saenz CC, Datnow B, Cui XS, et al
     Relocalized p27Kip1 Tumor Suppressor Functions as a Cytoplasmic Metastatic Oncogene in Melanoma.
     Cancer Res. 2007;67:9238-43.
     PubMed     Related articles    Abstract available
     
     
     
170. PARK E , Zhu F, Liu B, Xia X, et al
     Reduction in I{kappa}B Kinase {alpha} Expression Promotes the Development of Skin Papillomas and Carcinomas.
     Cancer Res. 2007;67:9158-68.
     PubMed     Related articles    Abstract available
     
     
     
171. JONES R , Ruas M, Gregory F, Moulin S, et al
     A CDKN2A Mutation in Familial Melanoma that Abrogates Binding of p16INK4a to CDK4 but not CDK6.
     Cancer Res. 2007;67:9134-41.
     PubMed     Related articles    Abstract available
     
     
     
172. LAUBER SN , Gooderham NJ
     The Cooked Meat Derived Genotoxic Carcinogen 2-Amino-3-Methylimidazo[4,5-b]Pyridine Has Potent Hormone-Like Activity: Mechanistic Support for a Role in Breast Cancer.
     Cancer Res. 2007;67:9597-602.
     PubMed     Related articles    Abstract available
     
     
     
173. BERWICK M , Satagopan JM, Ben-Porat L, Carlson A, et al
     Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.
     Cancer Res. 2007;67:9591-6.
     PubMed     Related articles    Abstract available
     
     
     
174. SCHMIDT MK , Reincke S, Broeks A, Braaf LM, et al
     Do MDM2 SNP309 and TP53 R72P Interact in Breast Cancer Susceptibility? A Large Pooled Series from the Breast Cancer Association Consortium.
     Cancer Res. 2007;67:9584-90.
     PubMed     Related articles    Abstract available
     
     
     
175. HONG S , Lee C, Kim SJ
     Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway.
     Cancer Res. 2007;67:9577-83.
     PubMed     Related articles    Abstract available
     
     
     
176. WITTMANN BM , Sherk A, McDonnell DP
     Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.
     Cancer Res. 2007;67:9549-60.
     PubMed     Related articles    Abstract available
     
     
     
177. ZHENG Y , Zhou H, Modzelewski JR, Kalak R, et al
     Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
     Cancer Res. 2007;67:9542-8.
     PubMed     Related articles    Abstract available
     
     
     
178. KOSLOWSKI M , Sahin U, Mitnacht-Kraus R, Seitz G, et al
     A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.
     Cancer Res. 2007;67:9528-34.
     PubMed     Related articles    Abstract available
     
     
     
179. JAKOBSEN CG , Rasmussen N, Laenkholm AV, Ditzel HJ, et al
     Phage Display Derived Human Monoclonal Antibodies Isolated by Binding to the Surface of Live Primary Breast Cancer Cells Recognize GRP78.
     Cancer Res. 2007;67:9507-17.
     PubMed     Related articles    Abstract available
     
     
     
180. AQEILAN RI , Donati V, Gaudio E, Nicoloso MS, et al
     Association of Wwox with ErbB4 in Breast Cancer.
     Cancer Res. 2007;67:9330-6.
     PubMed     Related articles    Abstract available
     
     
     
181. DEGEN M , Brellier F, Kain R, Ruiz C, et al
     Tenascin-W Is a Novel Marker for Activated Tumor Stroma in Low-grade Human Breast Cancer and Influences Cell Behavior.
     Cancer Res. 2007;67:9169-79.
     PubMed     Related articles    Abstract available
     
     
     
182. YAN W , Chen X
     Targeted Repression of Bone Morphogenetic Protein 7, a Novel Target of the p53 Family, Triggers Proliferative Defect in p53-Deficient Breast Cancer Cells.
     Cancer Res. 2007;67:9117-24.
     PubMed     Related articles    Abstract available
     
     
     
183. LO HW , Hsu SC, Xia W, Cao X, et al
     Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.
     Cancer Res. 2007;67:9066-76.
     PubMed     Related articles    Abstract available
     
     
     
184. GADI VK , Nelson JL
     Fetal microchimerism in women with breast cancer.
     Cancer Res. 2007;67:9035-8.
     PubMed     Related articles    Abstract available
     
     
     
185. LAPIERRE M , Siegfried G, Scamuffa N, Bontemps Y, et al
     Opposing Function of the Proprotein Convertases Furin and PACE4 on Breast Cancer Cells' Malignant Phenotypes: Role of Tissue Inhibitors of Metalloproteinase-1.
     Cancer Res. 2007;67:9030-4.
     PubMed     Related articles    Abstract available
     
     
     
186. EDDY SF , Kane SE, Sonenshein GE
     Trastuzumab-Resistant HER2-Driven Breast Cancer Cells Are Sensitive to Epigallocatechin-3 Gallate.
     Cancer Res. 2007;67:9018-23.
     PubMed     Related articles    Abstract available
     
     
     September 2007
187. MELANA SM , Nepomnaschy I, Sakalian M, Abbott A, et al
     Characterization of viral particles isolated from primary cultures of human breast cancer cells.
     Cancer Res. 2007;67:8960-5.
     PubMed     Related articles    Abstract available
     
     
     
188. MCGOWAN EM , Russell AJ, Boonyaratanakornkit V, Saunders DN, et al
     Progestins Reinitiate Cell Cycle Progression in Antiestrogen-Arrested Breast Cancer Cells through the B-Isoform of Progesterone Receptor.
     Cancer Res. 2007;67:8942-51.
     PubMed     Related articles    Abstract available
     
     
     
189. CHEN D , Reierstad S, Lin Z, Lu M, et al
     Prostaglandin E2 Induces Breast Cancer Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose Fibroblasts.
     Cancer Res. 2007;67:8914-22.
     PubMed     Related articles    Abstract available
     
     
     
190. MIAO ZH , Player A, Shankavaram U, Wang YH, et al
     Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses.
     Cancer Res. 2007;67:8752-61.
     PubMed     Related articles    Abstract available
     
     
     
191. BUIJS JT , Henriquez NV, van Overveld PG, van der Horst G, et al
     Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
     Cancer Res. 2007;67:8742-51.
     PubMed     Related articles    Abstract available
     
     
     
192. HARPER J , Yan L, Loureiro RM, Wu I, et al
     Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24.
     Cancer Res. 2007;67:8736-41.
     PubMed     Related articles    Abstract available
     
     
     
193. LI X , Shen L, Zhang J, Su J, et al
     Degradation of HER2 by Cbl-based chimeric ubiquitin ligases.
     Cancer Res. 2007;67:8716-24.
     PubMed     Related articles    Abstract available
     
     
     
194. TANG B , Yoo N, Vu M, Mamura M, et al
     Transforming Growth Factor-{beta} Can Suppress Tumorigenesis through Effects on the Putative Cancer Stem or Early Progenitor Cell and Committed Progeny in a Breast Cancer Xenograft Model.
     Cancer Res. 2007;67:8643-52.
     PubMed     Related articles    Abstract available
     
     
     
195. SENG S , Avraham HK, Jiang S, Yang S, et al
     The Nuclear Matrix Protein, NRP/B, Enhances Nrf2-Mediated Oxidative Stress Responses in Breast Cancer Cells.
     Cancer Res. 2007;67:8596-604.
     PubMed     Related articles    Abstract available
     
     
     
196. GONZALEZ ME , Peterson EA, Privette LM, Loffreda-Wren JL, et al
     High SEPT9_v1 Expression in Human Breast Cancer Cells Is Associated with Oncogenic Phenotypes.
     Cancer Res. 2007;67:8554-64.
     PubMed     Related articles    Abstract available
     
     
     
197. KONISHI H , Karakas B, Abukhdeir AM, Lauring J, et al
     Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
     Cancer Res. 2007;67:8460-7.
     PubMed     Related articles    Abstract available
     
     
     
198. WOODFIELD GW , Horan AD, Chen Y, Weigel RJ, et al
     TFAP2C Controls Hormone Response in Breast Cancer Cells through Multiple Pathways of Estrogen Signaling.
     Cancer Res. 2007;67:8439-43.
     PubMed     Related articles    Abstract available
     
     
     
199. HUDSON TS , Hartle DK, Hursting SD, Nunez NP, et al
     Inhibition of Prostate Cancer Growth by Muscadine Grape Skin Extract and Resveratrol through Distinct Mechanisms.
     Cancer Res. 2007;67:8396-405.
     PubMed     Related articles    Abstract available
     
     
     
200. O'SHAUGHNESSY RF , Akgul B, Storey A, Pfister H, et al
     Cutaneous Human Papillomaviruses Down-regulate AKT1, whereas AKT2 Up-regulation and Activation Associates with Tumors.
     Cancer Res. 2007;67:8207-8215.
     PubMed     Related articles    Abstract available
     
     
     
201. VACHON CM , Sellers TA, Carlson EE, Cunningham JM, et al
     Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer.
     Cancer Res. 2007;67:8412-8.
     PubMed     Related articles    Abstract available
     
     
     
202. KLUCKY B , Mueller R, Vogt I, Teurich S, et al
     Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
     Cancer Res. 2007;67:8198-206.
     PubMed     Related articles    Abstract available
     
     
     
203. BROMBERG KD , Kluger HM, Delaunay A, Abbas S, et al
     Increased Expression of the E3 Ubiquitin Ligase RNF5 Is Associated with Decreased Survival in Breast Cancer.
     Cancer Res. 2007;67:8172-9.
     PubMed     Related articles    Abstract available
     
     
     
204. HITOSUGI T , Sato M, Sasaki K, Umezawa Y, et al
     Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells.
     Cancer Res. 2007;67:8139-48.
     PubMed     Related articles    Abstract available
     
     
     
205. DEEB KK , Michalowska AM, Yoon CY, Krummey SM, et al
     Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
     Cancer Res. 2007;67:8065-80.
     PubMed     Related articles    Abstract available
     
     
     
206. YUAN Y , Qin L, Liu D, Wu RC, et al
     Genetic Screening Reveals an Essential Role of p27kip1 in Restriction of Breast Cancer Progression.
     Cancer Res. 2007;67:8032-42.
     PubMed     Related articles    Abstract available
     
     
     
207. CHEN H , Zhang H, Lee J, Liang X, et al
     HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition.
     Cancer Res. 2007;67:8007-13.
     PubMed     Related articles    Abstract available
     
     
     
208. KOMINSKY SL , Tyler B, Sosnowski J, Brady K, et al
     Clostridium perfringens Enterotoxin as a Novel-Targeted Therapeutic for Brain Metastasis.
     Cancer Res. 2007;67:7977-82.
     PubMed     Related articles    Abstract available
     
     
     
209. CELIS E
     Toll-like receptor ligands energize peptide vaccines through multiple paths.
     Cancer Res. 2007;67:7945-7.
     PubMed     Related articles    Abstract available
     
     
     August 2007
210. PERROTTA C , Bizzozero L, Falcone S, Rovere-Querini P, et al
     Nitric Oxide Boosts Chemoimmunotherapy via Inhibition of Acid Sphingomyelinase in a Mouse Model of Melanoma.
     Cancer Res. 2007;67:7559-64.
     PubMed     Related articles    Abstract available
     
     
     
211. MA C , Wang J, Gao Y, Gao TW, et al
     The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
     Cancer Res. 2007;67:7756-64.
     PubMed     Related articles  &